Sökning: "Mikael Lilja"
Hittade 5 avhandlingar innehållade orden Mikael Lilja.
1. Trends in obesity and type 2 diabetes : ethnic aspects and links to adipokines
Sammanfattning : Objective The prevalence of obesity and related diseases such as type 2 diabetes mellitus (T2DM) is increasing worldwide, and the Asian Indian population seems to be particularly susceptible to developing T2DM, even at a low body mass index (BMI). In Sweden, the age-adjusted prevalence of diabetes has not increased despite increasing self-reported obesity. LÄS MER
2. Digital Twins : High Resolution Disease Models for Optimized Diagnosis and Treatment
Sammanfattning : To study immune-mediated diseases, which can affect the expression of thousands of genes among many different cell types and organs, is a daunting challenge. However, for effective diagnosis and therapeutic treatment it is relevant to understand the regulatory functions of disease. LÄS MER
3. Creating access to cancer care : an exploration of patient-provider encounters in primary care, and sociodemographic factors
Sammanfattning : Background: Access to care is widely discussed in both research and practice. However, previous research about access to care has mainly focused on individual behaviors of seeking care, and theories about access have mostly focused on quantifiable dimensions, such as supply and demand. LÄS MER
4. Diagnosing colorectal cancer in primary care : the value of symptoms, faecal immunochemical tests, faecal calprotectin and anaemia
Sammanfattning : Background: Colorectal cancer (CRC) is the third most common cancer in men and the second most common in women worldwide. Adenomas can be precursors to CRC, and inflammatory bowel disease (IBD) can present with the same symptoms as CRC. The majority of patients with CRC initially consult primary care. LÄS MER
5. Faecal Calprotectin Diagnostics : Focus on Primary Care and Suspected Sources of Error
Sammanfattning : Patients with gastrointestinal symptoms often present a diagnostic challenge for general practitioners. Faecal calprotectin (FC) is commonly used as a marker of intestinal inflammation and is useful for differentiating between inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as for the follow-up of patients with IBD and monitoring treatment response. LÄS MER